Genetic basis of diabetic nephropathy

Hernan Rincon-Choles, Farook Thameem, Donna M. Lehman, Rector Arya, Nedal Arar, Ravindranath Duggirala, Michael P. Stern, Hanna E. Abboud

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Diabetes mellitus is the leading cause of end-stage renal disease. Development and progression of diabetic nephropathy result from a combination of genetic susceptibility and metabolic and hemodynamic abnormalities. In America, some racial and ethnic minorities have a significant burden of diabetic nephropathy, and, although genetic studies suggest that inherited factors play a major role in the pathogenesis of diabetic nephropathy, little information has been gained on the genes and molecular mechanisms involved. The genetic background of diabetic nephropathy is believed to be polygenic, and the genes predisposing to the development and progression of diabetic nephropathy are actively being investigated. New knowledge in identifying and understanding the role of susceptibility gene(s) will provide valuable information that could help develop new preventive and therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)555-561
Number of pages7
JournalAmerican Journal of Therapeutics
Issue number6
StatePublished - Nov 2005


  • Diabetes
  • Diabetic nephropathy
  • Genetics
  • Linkage analysis
  • Mexican Americans
  • Microalbuminuria
  • Proteinuria

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Genetic basis of diabetic nephropathy'. Together they form a unique fingerprint.

Cite this